Polycystic ovary syndrome laboratory findings: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Polycystic ovary syndrome}} {{CMG}} ==Overview== ==Laboratory Findings== ===Electrolyte and Biomarker Studies=== It is vital to note that ''not all women w...")
 
No edit summary
Line 28: Line 28:
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Endocrinology]]
[[Category:Gynecology]]
[[Category:Medical conditions related to obesity]]
[[Category:Syndromes]]
[[Category:Human reproduction]]
[[Category:Overview complete]]
[[Category:Obstetrics]]

Revision as of 04:36, 20 September 2012

Polycystic ovary syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Polycystic ovary syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Polycystic ovary syndrome laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Polycystic ovary syndrome laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Polycystic ovary syndrome laboratory findings

CDC on Polycystic ovary syndrome laboratory findings

Polycystic ovary syndrome laboratory findings in the news

Blogs on Polycystic ovary syndrome laboratory findings

Directions to Hospitals Treating Polycystic ovary syndrome

Risk calculators and risk factors for Polycystic ovary syndrome laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Laboratory Findings

Electrolyte and Biomarker Studies

It is vital to note that not all women with PCOS have polycystic ovaries (PCO), nor do all women with ovarian cysts have PCOS; although a pelvic ultrasound is a major diagnostic tool, it is not the only one. Diagnosis can be difficult, particularly because of the wide range of symptoms and the variability in presentation (which is why this disorder is characterized as a syndrome rather than a disease).

  • Standard diagnostic assessments:
  • Common assessments for associated conditions or risks
    • Fasting biochemical screen and lipid profile
    • 2-hour oral glucose tolerance test (GTT) in patients with risk factors (obesity, family history, history of gestational diabetes) and may indicate impaired glucose tolerance (insulin resistance) in 15-30% of women with PCOS. Frank diabetes can be seen in 65–68% of women with this condition. Insulin resistance can be observed in both normal weight and overweight patients.
  • For exclusion of other disorders that may cause similar symptoms:

The role of other tests is more controversial, including:

  • Fasting insulin level or GTT with insulin levels (also called IGTT). Elevated insulin levels have been helpful to predict response to medication and may indicate women who will need higher dosages of Metformin or the use of a second medication to significantly lower insulin levels. Elevated blood sugar and insulin values do not predict who responds to an insulin-lowering medication, low-glycemic diet, and exercise. Many women with normal levels may benefit from combination therapy. A hypoglycemic response in which the two-hour insulin level is higher and the blood sugar lower than fasting is consistent with insulin resistance. A mathematical derivation known as the HOMAI, calculated from the fasting values in glucose and insulin concentrations, allows a direct and moderately accurate measure of insulin sensitivity.
  • LH:FSH ratio elevation; FSH normal or low, LH high. Measurement of LH and FSH is easy and fairly standard, but the pattern is not very specific and is seen in only a subset of patients; present in less than 50% in one study.[1]

References

  1. Banaszewska B, Spaczyński RZ, Pelesz M, Pawelczyk L (2003). "Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia". Rocz. Akad. Med. Bialymst. 48: 131–4. PMID 14737959.